Masimo (MASI) Net Cash Flow Growth (3y) (2012 - 2026)
Masimo (MASI) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -48.90% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 15.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 15.60% |
| Jan 3, 2026 | -68.38% |
| Sep 27, 2025 | -92.23% |
| Jun 28, 2025 | 27.18% |
| Mar 29, 2025 | 38.99% |
| Dec 28, 2024 | 1,043.47% |
| Mar 30, 2024 | 26.38% |
| Sep 30, 2023 | -31.53% |
| Jul 1, 2023 | -28.55% |
| Apr 1, 2023 | -47.38% |
| Dec 31, 2022 | -38.32% |
| Oct 1, 2022 | -32.82% |
| Jul 2, 2022 | -382.46% |
| Apr 2, 2022 | 45.23% |
| Jan 1, 2022 | -91.18% |
| Apr 3, 2021 | -54.31% |
| Sep 26, 2020 | 41.62% |
| Jun 27, 2020 | 62.33% |
| Mar 28, 2020 | 2.11% |
| Dec 28, 2019 | -33.95% |